Patents by Inventor Yelda Erdem

Yelda Erdem has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LOXOPROFEN AND GAMMA-AMINOBUTIRIC ACID RECEPTOR AGONIST COMBINATIONS
    Publication number: 20170151177
    Abstract: This invention is a novel pharmaceutical composition comprising loxoprofen or a pharmaceutically acceptable salt thereof in combination with gamma-aminobutiric acid receptor agonist or a pharmaceutically acceptable salt thereof with anti-inflammatory, analgesic and myorelaxant activity.
    Type: Application
    Filed: June 29, 2015
    Publication date: June 1, 2017
    Inventors: ÜMIT CIFTER, ALI TÜRKYILMAZ, YELDA ERDEM, SEVAL ATAMAN, AYSE ILDES ERDEM, GAYE RAMAZANOGLU
  • A NOVEL PHARMACEUTICAL COMPOSITION OF SOFOSBUVIR AND RIBAVIRIN
    Publication number: 20170151272
    Abstract: This invention is a novel pharmaceutical composition comprising sofosbuvir and ribavirin as active agents with at least one pharmaceutically acceptable excipient, wherein at least one of the active agents is in the form of controlled release, for use in the treatment of hepatitis C virus infections, chronic hepatitis C, hepatocellular carcinoma or patients with end-stage liver disease awaiting liver transplantation.
    Type: Application
    Filed: June 22, 2015
    Publication date: June 1, 2017
    Inventors: ÜMIT CIFTER, ALI TÜRKYILMAZ, YELDA ERDEM, EZGI UCAR, SEVGI GÖKCEK
  • MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS OF SOFOSBUVIR AND RIBAVIRIN
    Publication number: 20170128482
    Abstract: This invention is a novel modified release pharmaceutical composition comprising sofosbuvir and ribavirin and at least one pharmaceutically acceptable excipient for use in the treatment of hepatitis C virus infections, chronic hepatitis C (CHC), hepatocellular carcinoma or patients with end-stage liver disease awaiting liver transplantation.
    Type: Application
    Filed: June 22, 2015
    Publication date: May 11, 2017
    Inventors: ÜMIT CIFTER, ALI TÜRKYILMAZ, YELDA ERDEM, EZGI UCAR, SEVGI GÖKCEK
  • PHARMACEUTICAL COMBINATIONS OF SOFOSBUVIR AND RIBAVIRIN
    Publication number: 20170112867
    Abstract: This invention is a novel pharmaceutical composition comprising sofosbuvir and ribavirin and at least one pharmaceutically acceptable excipient for use in the treatment of hepatitis C virus infections, chronic hepatitis C (CHC), hepatocellular carcinoma or patients with end-stage liver disease awaiting liver transplantation.
    Type: Application
    Filed: June 22, 2015
    Publication date: April 27, 2017
    Inventors: ÜMIT CIFTER, ALI TÜRKYILMAZ, YELDA ERDEM, EZGI UCAR, SEVGI GÖKCEK
  • PHARMACEUTICAL FORMULATIONS COMPRISING QUETIAPINE AND ESCITALOPRAM
    Publication number: 20160008375
    Abstract: The present invention relates to a multilayer tablet formulation comprising a combination of quetiapine or a pharmaceutically acceptable salt thereof and escitalopram or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 27, 2014
    Publication date: January 14, 2016
    Inventors: Ali Turkyilmaz, Müge Ulusoy Bozyel, Yelda Erdem, Isin Ruiye Okyar